← Back
Data updated: Mar 10, 2026
SK LIFE
NeurologyOncologyGastroenterology
SK LIFE is a pharmaceutical company focused on Neurology, Oncology, Gastroenterology. Key products include XCOPRI.
2019
Since
1
Drugs
-
Trials
3
Approved (2yr)
Recent Activity
SEC Filings
Pro
Loading...
Therapeutic Focus
Score weights: Approved drugs ×3, Phase 3 ×2, Phase 2 ×1, Phase 1 ×0.5
Neurology 93%
1 drugs Phase 3: 5 Phase 1: 2
Oncology 3%
0 drugs Phase 1: 1
Gastroenterology 3%
0 drugs Phase 1: 1
Pipeline Strength Pro
Loading...
Active (1)
Discontinued (0)
Company Info
- First Approval
- 2019-11-21
- Latest
- 2025-08-18
- Applications
- 1